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Changes in gene expression are an important mechanism by which
activity levels are regulated in the nervous system. It is not known,
however, how network activity influences gene expression in in-
terneurons; since they themselves provide negative feedback in the
form of synaptic inhibition, there exists a potential conflict between
their cellular homeostatic tendencies and those of the network. We
present a means of examining this issue, utilizing simple in vitro
models showing different patterns of intense network activity. We
found that the degree of concurrent pyramidal activation changed
the polarity of the induced gene transcription. When pyramidal cells
were quiescent, interneuronal activation led to an upregulation of
glutamate decarboxylase 1 (GAD1) and parvalbumin (Pvalb) gene
transcriptions, mediated by activation of the Ras/extracellular signal-
related kinase mitogen-activated protein kinase (Ras/ERK MAPK)
pathway. In contrast, coactivation of pyramidal cells led to an iono-
tropic glutamate receptor N-methyl-D-aspartate 2B-dependent de-
crease in transcription. Our results demonstrate a hitherto unrecog-
nized complexity in how activity-dependent gene expression changes
are manifest in cortical networks.
NEW & NOTEWORTHY We demonstrate a novel feedback mech-
anism in cortical networks, by which glutamatergic drive, mediated
through the Ras/ERK MAPK pathway, regulates gene transcription in
interneurons. Using a unique feature of certain in vitro epilepsy
models, we show that without this glutamatergic feedback, intense
activation of interneurons causes parvalbumin and glutamate decar-
boxylase 1 mRNA expression to increase. If, on the other hand,
pyramidal cells are coactivated with interneurons, this leads to a
downregulation of these genes.
epilepsy; epileptogenesis; homeostasis; MAPK pathway; parvalbumin
INTRODUCTION
The interplay between gene expression changes and neuro-
nal activity is fundamental for normal brain function. Neuronal
excitability is determined by which genes are expressed, and in
turn, neuronal activity influences gene expression (Qiu and
Ghosh 2008; West et al. 2002). These reciprocal interactions
thus maintain functional stability and regulate metabolic re-
quirements. There are other processes, though, that occur
during development and learning, which rather than preserve
the status quo, instead lead to long-lasting changes in brain
networks (Beck and Yaari 2008; Karabanov et al. 2015).
Similarly, various brain insults, including brain trauma, stroke,
and infection, can lead to persistent pathological changes, such
as the tendency to suffer epileptic seizures (Beck and Yaari
2008). This change is termed epileptogenesis and represents a
major clinical problem because currently there is no prophy-
lactic therapy (Pitkänen and Lukasiuk 2011). There remains,
therefore, an urgent need to improve our understanding of how
such changes are regulated in cortical networks.
Activity-dependent gene expression changes are often dis-
cussed in terms of neuronal activity homeostasis (Davis 2006,
2013; Marder and Prinz 2002). Homeostasis within the in-
terneuronal population, however, may be more complex, be-
cause they themselves provide a different kind of negative
feedback, in the form of synaptic inhibition. To illustrate this
issue, consider the case where the entire network is active. If,
in response, interneurons downregulate their excitability, this
leads to a relative disinhibition of the network. If, on the other
hand, homeostasis is manifested at the network level instead of
at the cellular level, then a network-wide stimulation may
result in a paradoxical response in the interneuronal population
to increase their excitability. This latter case would represent a
situation where the network’s needs are prioritized over the
interneurons’ needs. These considerations would predict that
activity-dependent changes in interneuronal gene expression
are dictated by the level of concurrent pyramidal activity. To
test this hypothesis, we utilized the fact that certain simple
pharmacological manipulations of brain slice activity can in-
duce very different patterns of epileptiform discharges. One
manipulation (4-aminopyridine with glutamate receptor block-
ers; 4AP-GluX model) induces epileptiform activity only in the
interneuronal population, in contrast to bathing slices in 0
Mg2 artificial cerebrospinal fluid (ACSF), which triggers
epileptiform activity in the entire neuronal population. We
focused on the earliest detectable changes indicative of an
activity-dependent gene expression response, which is in the
mRNA transcript. We report here that the two patterns of
cortical activation, which differ primarily in the level of pyra-
midal involvement, induced opposite changes in mRNA ex-
pression levels of glutamate decarboxylase 1 (GAD1) and
parvalbumin (Pvalb) genes. These opposing gene expression
Address for reprint requests and other correspondence: A. J. Trevelyan, Inst.
of Neuroscience, Medical School, Framlington Place, Newcastle upon Tyne,
NE2 4HH, UK (e-mail: andrew.trevelyan@ncl.ac.uk).
J Neurophysiol 120: 2358–2367, 2018.
First published August 15, 2018; doi:10.1152/jn.00287.2018.
2358 Licensed under Creative Commons Attribution CC-BY 4.0: © the American Physiological Society. ISSN 0022-3077. www.jn.org
Downloaded from www.physiology.org/journal/jn by ${individualUser.givenNames} ${individualUser.surname} (128.240.225.045) on October 31, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
changes appear to be downstream of the glutamatergic-acti-
vated Ras/extracellular signal-related kinase mitogen-activated
protein kinase (Ras/ERK MAPK) pathway. Collectively, these
data suggest that activity-dependent changes in gene expression
are influenced by interactions between different cell classes.
METHODS
Tissue preparation. Procedures were performed according to the
guidelines of the Home Office UK Animals (Scientific Procedures)
Act of 1986. Adult male (2–4 mo) wild-type (C57/BL6) or PV-Cre
Het mice were used in this study. Mice were decapitated, and brains
were removed and stored in cold cutting solution (in mM): 3 MgCl2,
126 NaCl, 26 NaHCO3, 3.5 KCl, 1.26 NaH2PO4, and 10 glucose. For
local field potential (LFP) recordings, 400-m horizontal sections
containing the neocortex, entorhinal cortex, and hippocampus were
made, using a Leica VT1200 vibratome (Nussloch, Germany). Slices
were then transferred to an interface holding chamber and incubated
for 1–2 h at room temperature in ACSF containing (in mM): 2 CaCl2,
1 MgCl2, 126 NaCl, 26 NaHCO3, 3.5 KCl, 1.26 NaH2PO4, and 10
glucose. For patch-clamp experiments, 350-m coronal sections were
made but were stored in a submerged holding chamber for 1–4 h
before experimentation. All of the solutions were bubbled continu-
ously to saturate with carboxygen (95% O2 and 5% CO2).
Extracellular field recordings were performed using interface re-
cording chambers. Horizontal brain slices [approximately equivalent
to plate 155 in Franklin and Paxinos (2008)] were placed in the
recording chamber perfused with ACSF or modified to induce epilep-
tiform activity [0 Mg2/4AP (100 M, Sigma-Aldrich)/gabazine (10
mM, Tocris)] or to include various pharmacological agents [50 M
D-2-amino-5-phosphonovalerate (AP5, Hello-Bio, Bristol, UK), 20
M NBQX disodium salt (Hello Bio), 1 M Ro-25-6981 (Santa Cruz
Biotechnology, Heidelberg, Germany), and 20 M U0126 (New
England Biolabs, Hitchin, UK)]. Since U0126 and Ro-25-6981 were
both prepared in 0.1% dimethyl sulfoxide (DMSO), the parallel
control experiments were also run using 0.1% DMSO (but omitting
U0126 and Ro-25-6981).
Recordings were obtained using normal ACSF-filled 1–3 M
borosilicate glass microelectrodes (GC120TF-10; Harvard Apparatus,
Cambridge, UK) placed in deep layers of neocortex [corresponding to
temporal association area, plate 155 (Franklin and Paxinos 2008).
Experiments were performed at 33–36°C. The solutions were per-
fused at the rate of 3 ml/min. Waveform signals were acquired using
BMA-931 biopotential amplifier (Dataq Instruments, Akron, OH),
Micro 1401-3 ADC board (Cambridge Electronic Design, Cambridge,
UK), and Spike2 software (v. 7.10, Cambridge Electronic Design).
Signals were sampled at 10 kHz, amplified (gain: 500), and bandpass
filtered (1–3,000 Hz). A CED4001-16 Mains Pulser (Cambridge
Electronic Design) was connected to the events input of CED micro
1401-3 ADC board and used to remove 50-Hz hum offline. Extracel-
lular field recordings were analyzed to detect events using a custom-
written code in Matlab2015b (MathWorks, Natick, MA).
Viral injections. PV-Cre pups were injected with AAV5.Syn.
Flex.tdTomato, purchased from the University of Pennsylvania vector
core. Injections were performed on the day of birth. Pups were set on
a stereotaxic frame and anesthetized with isoflurane, following appli-
cation of EMLA cream (2.5% Lidocaine and 2.5% Prilocaine) to the
left top of their heads. Injections were made using 10 l of Hamilton
syringes with a beveled 36-gauge needle (World Precision Instru-
ments), unilaterally into the lateral ventricle and overlying cortical
plate, at ~1 mm anterior to lambda and 1 mm lateral to the midline
into the left hemisphere, starting at 1.7 mm deep from the top of the
dura mater, for a total of four separate 50-nl injections, the deepest
first and coming up 0.3 mm for each subsequent injection. Approxi-
mately 200 nl (1,000 viral particles) was injected into the left
hemisphere over a 10-min period. Pups were monitored until they
awoke following the procedure and then returned to their home cage.
These neonatal injections produced widespread cortical expression of
tdTomato into the parvalbumin positive (PV) cells.
Patch-clamp recordings. Slices were perfused at 3–5 ml/min and
heated to 33–34°C. Whole cell data were acquired using pClamp
software, Multiclamp 700B, and Digidata acquisition board (Molec-
ular Devices, Sunnyvale, CA). Whole cell and cell-attached record-
ings were made using 4- to 7-M pipettes. Pipettes were filled with
a KMeSO4-based internal solution containing (in mM) 125 KMeSO4,
6 NaCl, 10 HEPES, 2.5 Mg-ATP, 0.3 Na2-GTP, and 5% (wt/vol)
biocytin. For the voltage clamp recordings, 5 mM QX-314 [N-(2,6-
dimethylphenylcarbamoylmethyl) triethylammonium bromide; Sigma-
Aldrich] was added to the internal solution. Osmolarity and pH of
all the internal solutions used were adjusted to 284 mOsm and 7.4,
respectively. PV cells were identified using tdTomato for targeted
cell-attached recordings.
Tissue collection. After 1 h of recordings, tissue was immersed in
Ambion RNAlater solution (Thermo Fisher Scientific, Cramlington,
UK), the neocortex was subdissected away from the entorhinal cortex
and the hippocampus and then stored in RNAlater solution, at 4°C
until the RNA was extracted (see approximate area indicated in the
schematic in Fig. 3Aiii).
RNA preparations. RNA was extracted using the RNAqueous-
Micro Total RNA Isolation Kit (Thermo Fisher Scientific) and eluted
in 15 l of provided elution buffer. Residual genomic DNA was
removed using reagents supplied in the above-mentioned kit and done
according to the manufacturer’s instructions. Concentration and purity
of RNA were determined using a BioDrop DUO (BioDrop, Cam-
bridge, UK). RNA was then stored at 80°C until the cDNA library
preparation.
Real-time PCR. Samples were normalized to 100 ng for cDNA
library preparation. cDNA synthesis was performed using the Applied
Biosystems High-Capacity cDNA Reverse Transcription Kit (Thermo
Fisher Scientific) in a Thermo Hybaid PCR Express Thermal Cycler
(Thermo Hybaid, Ashford, UK) at a total volume of 20 l. The cDNA
was diluted 1:4 for the neocortical samples with nuclease-free H2O.
The following primers were used for the real-time (RT)-PCR: Pvalb
(For: attgaggaggatgagctggg, Rev: cgagaaggactgagatgggg), GAD1
(For: gcctggaagagaagagtcgt, Rev: tccccgttcttagctggaag), glyceralde-
hyde-3-phosphate dehydrogenase (Gapdh) (For: acctttgatgctgg-
ggctggc, Rev: gggctgagttgggatggggact). q-PCR amplifications were
performed on an Applied Biosystems Step One Plus RT PCR system
(Thermo Fisher Scientific) at 95°C for 10 min, and then 40 repeats of
the following cycle: 95°C for 10 s, followed by 58°C for 30 s and
95°C for 15 s. This protocol was immediately followed by the melt
curve starting at 95°C for 15 s, 60°C for 1 min, 95°C for 15 s, and,
finally, held at 4°C. All samples were run in duplicate at a primer
molarity of 10 mol/l. Pvalb and GAD1 were compared with Gapdh.
Expression of Gapdh was unchanged across all treatment groups (data
not shown). Cycle threshold (CT) values were analyzed using the
comparative CT method to calculate differences in gene expression
between samples. Melt curve analysis was used to confirm there was
a single product from each primer, and samples were run on a DNA
agarose gel to confirm expected product size and melt curve results.
Statistical analysis. Relative mRNA fold changes for all genes
were analyzed using the comparative CT method. Due to a lack of
homogeneity of variance between groups (Brown-Forsythe test and
Bartlett’s test), mRNA expression data were first transformed using a
square root transformation. Square root transformation of mRNA data
resulted in a nonsignificant Brown-Forsythe test and Bartlett’s test.
Transformed mRNA data and electrophysiology data of three or more
groups were anaylzed using a one-way analysis of variance (ANOVA)
with Tukey’s post hoc test. All mRNA data are displayed as they were
analyzed, as the square root of the relative value. Electrophysiology
data of only two groups were analyzed using Student’s t-test. Signif-
icance was set at P  0.05 for all analyses. Figures of mRNA
expression and event detection, along with all statistics, were done
using GraphPad Prism (GraphPad Software, La Jolla, CA). Figures of
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electrophysiology traces were created in Igor Pro (WaveMetrics, Lake
Oswego, OR).
RESULTS
Different epileptiform activity induced by 0 Mg2 and
4-aminopyridine. Epileptiform activity can be induced in brain
slices by a variety of simple pharmacological manipulations,
including removal of Mg2 ions from the bathing medium or
addition of the K channel blocker 4-aminopyridine (4AP)
(Swartzwelder et al. 1987; Ives and Jefferys 1990). Electro-
physiological recordings in both cases showed evidence of
intense and widespread neuronal activation (Fig. 1). Ca2
network imaging and patch clamp studies, on the other hand,
presented a more detailed and nuanced view of local neuronal
involvement. Importantly, both models showed very intense
and repeated activation of the interneuronal population (Fig. 1,
A and B) including fast-spiking interneurons. As such, these
paradigms present a means to examine how this critical class of
interneuron may react to induced intense activation. The two
models differ markedly, however, in the level of pyramidal
activation. In the 0 Mg2 model, the earliest discharges have a
predominantly interneuronal involvement but with limited py-
ramidal cell activity; however, this changes with the occur-
rence of the start of full ictal events, and thereafter, all neurons
Fig. 1. Differential neuronal involvement in epileptiform discharges induced by 0 Mg2 or by 4-aminopyridine (4AP). A: paired recordings of neighboring layer
5 pyramidal cells (P; whole cell, voltage clamp at 30 mV) and fast-spiking interneurons (FSI; cell attached) recorded during epileptiform bursts induced by
bathing brain slices in 0 Mg2 (representative example; n  6 slices). B: similar paired recordings shortly after bath application of 100 M 4AP, also showing
very intense bursting of fast-spiking interneurons coincident with the timings of -aminobutyric acid (GABA)ergic barrages onto the pyramidal cells
(representative example; n  4 slices). C: paired voltage clamp whole cell recordings (P1 held at 30 mV, and P2 at 60 mV, close to EGABA) from closely
apposed (50 m) layer 5 pyramidal cells during transient interictal discharges in 0 Mg2 artificial cerebrospinal fluid (ACSF) (representative example; n 
3 slices). Note particularly the large downward deflection in P2, demonstrating the presence of a large glutamatergic component in these events. D: similar
recordings in 4AP (representative example; n  3 slices). Note the almost complete absence of any glutamatergic activity in the P2 recording, consistent with
the key feature of the right panels, which is that, in current clamp, with a depolarizing drive to induce firing, the GABAergic barrages can veto even this artificial
excitation.: extracellular recordings of local field potentials (LFPs) in layer 5 in 0 Mg2 (representative example; n 3 slices; E) and 4AP with glutamate receptor
blockers (4AP-GluX) models (representative example; n 3 slices; F). Note the opposite effects of gabazine, which leads to an increase in electrographic activity
in the 0 Mg2 model (E) but a blockade of it in the 4AP-GluX model (F).
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are activated in most, if not every discharge (Fig. 1C) (Trev-
elyan et al. 2006; Parrish et al. 2018). In contrast, the early
activity in the 4AP model appears to lack any significant
pyramidal involvement; voltage clamp recordings show mini-
mal deflections (Fig. 1D), when the cell is held at close to the
GABAergic reversal potential (contrast this with equivalent
recordings in 0 Mg2, Fig. 1C), whereas, if the pyramidal cell
is held in current clamp, there is a pronounced inhibition of
firing during the discharges (Fig. 1D, right). Multiple studies
have noted that the 4AP model can subsequently progress to
full ictal activation (including pyramidal involvement) (Galvan
et al. 1982; Avoli et al. 2002). This early activity pattern can be
stabilized, however, by adding the glutamatergic blockers
NBQX and AP5, to the 4AP bathing medium (4AP-GluX)
(Avoli et al. 2002; Bohannon and Hablitz 2018). If one then
applies the -aminobutyric acid A (GABAA) receptor antago-
nist gabazine in the 4AP-GluX, there is a rapid cessation of all
electrographic activity recorded extracellularly (Fig. 1F), in
stark contrast to what happens in the 0 Mg2, where gabazine
induces a pronounced escalation of activity (Fig. 1E). These
two different patterns of activity can be demonstrated from a
single slice (Fig. 2 and Supplemental Movies S1, S2, and S3;
supplemental materials for this article are available on the
Journal of Neurobiology website), where washout of Mg2
ions leads to widespread neuronal activation, with 95 active
cells during a seizure event (Fig. 2A and Supplemental Movie
S1). In contrast, following Mg2 ions being washed back in,
and with the addition also of 4AP-GluX, we recorded only
induced pluripotent stem cells (iPSCs) in the postsynaptic
pyramidal cell (Fig. 2B), and, with minimal network activity,
just four active cells at the times of the synaptic bursts (Fig. 2B
and Supplemental Movies S2 and S3).
Pyramidal coactivation alters gene transcription changes in
PV interneurons. Aside from what these models might tell us
about epilepsy, they have an added utility, because, although
both show intense interneuronal activation, the level of pyra-
midal involvement is very different: high in 0 Mg2 and low in
4AP. Thus, a comparison of these models allowed a direct test
of our hypothesis, that gene expression in the interneuron
network is affected by the level of pyramidal cell activity. We
examined two target genes, GAD1 and Pvalb, which are
selectively expressed in inhibitory interneurons, and which are
also known to be dynamically regulated due to differential
stimuli (Donato et al. 2013; Hanno-Iijima et al. 2015). It is also
relevant that PV-expressing interneurons are an important
network component in both the 0 Mg2 model and the 4AP
model (Fig. 1) (Cammarota et al. 2013; Sessolo et al. 2015).
We exposed brain slices to one of four different bathing media
[1: control ACSF; 2: 0 Mg2 ACSF; 3: 4AP-GluX; 4: gluta-
matergic blockers in control ACSF (GluX)] for 1 h while
recording activity using extracellular electrodes (Fig. 3A). In
brain slices with activation oly of interneurons (4AP-GluX),
we found highly significant increases in mRNA expression of
both the GAD1 and Pvalb genes (Fig. 3, B and C). In contrast,
when interneurons were coactive with pyramidal cells, (0
Mg2 ACSF), both genes showed the opposite change, with a
highly significant decrease (Fig. 3, B and C). Furthermore,
there was a highly significant difference between the levels of
mRNA expression of these genes between the two models.
Bathing slices in normal ACSF with glutamatergic blockers
resulted in no change in GAD1 or Pvalb mRNA expression
(Fig. 3, B and C).
Different brain slices showed variation in the degree of
epileptiform activation, with the 0 Mg2 model typically
Fig. 2. Simple in vitro pharmacological manipulations can be
used to induce disparate patterns of epileptiform discharges
involving varying decreases of cellular activity. A: activity
patterns in the 0 Mg2 model, as manifested in whole cell
recordings of layer 5 pyramidal cells in voltage clamp mode
(30 mV holding potential) with simultaneous Ca2 net-
work imaging (Aii–iv). Note the widespread activation (95
active cells shown in red, Aiv). B: continued recording of the
same cell and field of view after switching to the 4-amino-
pyridine with glutamate receptor blockers (4AP-GluX)
model. Note the minimal cellular recruitment (4 active cell)
during what appear to be large electrographic events as
recorded in patch clamp mode.
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inducing more discharges than the 4AP model (Fig. 3B). This
factor, though, cannot explain the differences in gene expres-
sion between the groups, first, because the expression patterns
were in opposing directions; second, in the 4AP-GluX model
there was a highly significant correlation with the degree
change in gene expression and the amount of activity (Fig. 3,
E and F), suggesting that, if these slices had shown similar
levels of activation to the 0 Mg2 model, the difference
between the models might have been even greater. The 0 Mg2
model showed no correlation between the number of local field
potential (LFP) events detected in the neocortex with the
decrease in expression of both GAD1 and Pvalb mRNA
(GAD1, r2  0.004, P  0.4424; Pvalb, r2  0.117, P 
0.2036).
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GAD1 and Pvalb transcription is modulated by GluN2B-
containing NMDA receptors and Ras/ERK MAPK pathway.
Collectively, these data suggest that the gene-transcription
response in interneurons is critically affected by whether or not
there is coactivation of pyramidal cells. We hypothesized that
glutamatergic drive onto the interneurons, in the 0 Mg2
model, might influence the nature of the gene transcription
profile. One candidate for mediating this effect is the Ras/ERK
MAPK pathway, since it is known to be activity dependent
(Thomas and Huganir 2004). Furthermore, its regulation is
directly tied to fluctuations of Ca2 concentrations and is also
surprisingly sensitive to the mechanism of Ca2 entry into the
cell (Thomas and Huganir 2004). Specifically, Ca2 entering
through GluN2B-containing NMDA receptors (NMDARs),
which are primarily extrasynaptic, deactivates the Ras/ERK
MAPK pathway, whereas other modes of Ca2 entry into the
cell, such as through GluN2A-containing NMDARs and volt-
age-gated Ca2 channels result in activation of the Ras/ERK
MAPK pathway. GAD1 and Pvalb expression can also be
regulated by Ca2 fluctuations either through NMDARs and/or
voltage-gated calcium channels (Cohen et al. 2016; Harding-
ham and Bading 2010; Kim et al. 2005), and their expression
has been demonstrated in some cases to be downstream of the
Ras/ERK MAPK pathway (Hanno-Iijima et al. 2015; Patz et al.
2003, 2004). We therefore investigated how Ca2 entry might
explain the divergent patterns of gene transcription changes
seen in the two models.
The increased gene transcription seen in the 4AP-GluX
model was prevented by U0126 (Fig. 4), which suppresses
the Ras/ERK MAPK pathway through its action on MEK1.
Importantly, this occurs without altering the intensity of
epileptiform activity, quantified by time to first event (Fig.
Fig. 3. Glutamate decarboxylase 1 (GAD1) and parvalbumin (Pvalb) gene transcriptions are regulated differently when interneurons are activated in isolation vs.
when activated with the whole network in tandem. Ai: representative epileptiform discharges from the 0 Mg2 model. Aii: representative epileptiform discharges
from the 4-aminopyridine with glutamate receptor blockers (4AP-GluX) model. Aiii: schematic to show the location of the electrode recording the local field
potential (LFP) and the source of the tissue for analysis of the neocortical mRNA transcription analyses. B: GAD1 mRNA expression in the neocortex was
significantly downregulated due to total network activation (0 Mg2). Oppositely, GAD1 mRNA expression was significantly increased in the neocortex due to
selective interneuronal activation [4AP-GluX, n  8 for artificial cerebrospinal fluid (ACSF), 0 Mg2, and 4AP-glutamate receptor (GluR) blocker groups; n 
4 for GluR blockers group; ***P  0.001 relative to ACSF; ###P  0.001 between relevant experiment groups). C: Pvalb mRNA expression was significantly
decreased due to network activation (0 Mg2). Oppositely, its expression was significantly increased due to interneurnal activity (4AP-GluX, n  8 for ACSF,
0 Mg2, and 4AP-GluR blockers groups; n  4 for GluR blocker group; **P  0.01 relative to ACSF, ***P  0.001 relative to ACSF; ###P  0.001 between
relevant experiment groups). D: quantification of the number of events produced between induction of total network activity using the 0 Mg2 model and the
events produced using the 4AP-GluX model in the neocortex (n  8; ****P  0.0001, *P  0.05). E: GAD1 mRNA expression in the neocortex is activity
dependent following the selective interneuronal activation (4AP-GluX; n  8, r2  0.6362, P  0.0089). F: Pvalb mRNA expression in the neocortex is activity
dependent following the selective interneuronal activation (4AP-GluX; n  8, r2  0.7760, P  0.0019).
Fig. 4. Upregulation of glutamate decarboxylase 1 (GAD1) and parvalbumin (Pvalb) gene transcription is blocked by MAPK kinase (MEK) inhibition in the
4-aminopyridine with glutamate receptor blockers (4AP-GluX) model. A: increase of GAD1 mRNA expression due to selective interneuronal activation
(4AP-GluX) was blocked by application of the MEK inhibitor U0126 (n  5; *P  0.05 relative to ACSF; ##P  0.01 between relevant experiment groups).
B: increase of Pvalb mRNA expression due to selective interneuronal activation (4AP-GluX) was blocked by application of MEK inhibitor (n  5; **P  0.01
relative to ACSF; ##P  0.01 between relevant experiment groups). C: MEK inhibition did not significantly alter time to first event (n  5). D: MEK inhibition
did not significantly alter the activity generated in the 4AP-GluX model (n  5).
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4C) and total number of events over the hour-long recording
(Fig. 4D).
U0126 also prevented the change in gene transcription in the
0 Mg2 model (Fig. 5, A and B). The interpretation of this
result, though, is complicated by the fact that U0126 signifi-
cantly reduced the level of neuronal activity (Fig. 5, C–E),
preventing virtually all seizure-like events in five of six slices,
consistent with the findings from a previous study (Merlo et al.
2004). Interestingly, there continued to be a high level of
interictal activity (Fig. 5E). This activity, similarly to the
4AP-induced discharges, was dominated by interneuronal fir-
ing and low pyramidal involvement (Schevon et al. 2012).
Notably, in the one slice in U0126 that did show multiple
seizure-like events (that is, high pyramidal involvement; Fig. 5,
C–E, arrows), the mRNA expression levels of GAD1 and Pvalb
were comparable with the data from the 0 Mg2 model without
U0126, consistent with the interpretation that the key trigger
for reducing the Pvalb and GAD1 mRNA were the episodes of
intense pyramidal activation.
Blocking GluN2B-containing NMDARs with Ro25-6981
prevented the decrease in GAD1 and Pvalb expression seen in
the 0 Mg2 model (Fig. 4, A and B), but in contrast to the
U0126 result, Ro25-6981 did so without altering the intensity
of epileptiform activity, quantified by the total number of
seizures (Fig. 4C), time to first seizure event (Fig. 4D), and
total number of events (Fig. 4E). Thus, its antagonistic effect
Fig. 5. Decrease in glutamate decarboxylase 1 (GAD1) and parvalbumin (Pvalb) gene transcription is reversed by blocking extrasynaptic GluN2B-containing
N-methyl-D-aspartate (NMDA) receptors in the 0 Mg2 model. A: downregulation of neocortical GAD1 mRNA expression due to total network activity (0 Mg2)
was blocked by specific extrasynaptic GluN2B-containing NMDA receptor inhibitor Ro25-6981 (n  5–6; ***P  0.001 relative to ACSF; ##P  0.01 between
relevant experiment groups). B: decrease of Pvalb mRNA expression due to total network activity was blocked by extrasynaptic GluN2B-containing NMDA
receptor inhibitor in the neocortex (n  5–6; *P  0.05 relative to ACSF; ##P  0.01 between relevant experiment groups). C: blocking extrasynaptic
GluN2B-containing NMDA receptors had no effect on number of seizures. Inhibition of U0126, a nonselective MAPK kinase (MEK) inhibitor significantly
reduced seizures (n  5–6; *P  0.05 relative to 0 Mg2 and 0 Mg2  Ro25-6981). D: blocking the extrasynaptic GluN2B containing NMDA receptors had
no effect on ictal start time (n  5). E: blocking of extrasynaptic GluN2B-containing NMDA receptors (Ro25-6981) and blocking the MEK pathway had no
significant effect on total activity generated by removal of Mg2 ions (n  5–6).
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was downstream of the increase in neuronal activity. These
data suggest that decreased neocortical GAD1 and Pvalb
mRNA expression was induced by Ca2 entry via the GluN2B-
containing NMDARs, presumably, due to glutamate spillover
and activation of the extrasynaptic NMDARs. Taken together,
these data suggest a novel feedback mechanism regulating
interneuronal transcript expression, based on the glutamatergic
drive they receive.
DISCUSSION
We have described two experimental conditions sharing a
common feature of sustained intense bursting of interneurons
but differing in the degree of pyramidal involvement and which
lead to divergent gene transcription changes. The difference
between the two conditions appears to be whether or not the
pyramidal cell population is coactive. We have further shown
how these gene expression responses are mediated via Ca2
entry through GluN2B-containing NMDARs and downstream
of the Ras/ERK MAPK pathway. Figure 6 illustrates the
putative chain of network and molecular events underlying the
two different gene expression outcomes. The Ras/ERK MAPK
pathway is regulated by activity-dependent Ca2 entry
(Thomas and Huganir 2004), which in turn influences GAD1
and Pvalb mRNA expression and determines the direction of
their expression. Ca2 influx has a bidirectional effect on the
activation of the Ras/ERK MAPK pathway, depending on
whether entry occurs via GluN2A-containing NMDARs
(mainly synaptic) or GluN2B-containing NMDARs (mainly
extrasynaptic): GluN2A entry activates the Ras/ERK MAPK
pathway, whereas GluN2B entry downregulates it (Harding-
ham and Bading 2010; Kim et al. 2005). Seizure-like levels of
neuronal activation, particularly, are likely to favor entry
through the extrasynaptic GluN2B-containing NMDARs
(Hardingham and Bading 2010), which explains why the 0
Mg2 paradigm results in reduced GAD1 and Pvalb mRNA
expression. This interpretation is consistent with other studies
showing that blocking the Ras/ERK MAPK pathway decreases
GAD1 expression (Patz et al. 2004) and, second, that GAD1,
GAD2, and Pvalb expression are activity dependent and down-
stream of Ca2 entry (Cohen et al. 2016), and activation of the
Ras/ERK MAPK pathway (Hanno-Iijima et al. 2015; Patz et al.
2003). An interesting parallel with our data is that the direction
of change of PV and GAD67 (the protein product of GAD1)
can also be dictated by different behavioral experiences (Do-
nato et al. 2013), although this study did not relate these
changes to the involvement of pyramidal cells or the molecular
pathways that transduce this interaction.
Blockade of Ras/ERK MAPK has previously been shown to
reduce 4AP seizure-like events (Merlo et al. 2004), and we
confirm this in the 0 Mg2 model, although, notably in both
models, the repeated discharges associated with interneuronal
bursts (interictal events) are not suppressed. This suggests that
interneurons and pyramidal cells show different Ras/ERK
MAPK pathway behavior, which is further supported by re-
ports that seizure activity induces activation of this pathway in
pyramidal cells (Merlo et al. 2004) but inhibits it in GAD-
positive interneurons (Choi et al. 2007).
Our findings represent an important nuance to the conven-
tional paradigm of neuronal activity homeostasis, suggesting
the possibility that, when there is intense interneuronal activa-
tion alone, they show one pattern of gene transcription change;
but when there is widespread network activation, then their
response is modulated by the concurrent pyramidal activity.
Previous paradigms examining changes in neuronal firing rate
typically have done so over periods of days (Turrigiano et al.
1994), and we did not see any evidence of a reactive drop in
activity within the 1-h recordings. The level of GAD1 mRNA
expression, however, is likely to influence the pattern of
feedback inhibition within the network. Our findings are thus
very relevant to epileptogenesis, the protracted process
whereby cortical networks undergo extensive reorganization
leading to the occurrence of repeated spontaneous seizures.
Although many researchers have documented a wide range of
changes associated with this process (Dengler et al. 2017;
Pitkänen and Engel 2014; Terrone et al. 2016), we still do not
know which are the pivotal cellular changes (Pitkänen et al.
2015), and consequently, we still lack the scientific grounding
Fig. 6. Model of mechanisms driving the differential transcription of glutamate decarboxylase 1 (GAD1) and parvalbumin (Pvalb) genes in parvalbumin protein
(PV) cells in the 2 different types of epileptiform activity. A: full network activation (pyramidal activation; 0 Mg2) leads to spillover of glutamate, activating
extrasynaptic GluN2B-containing N-methyl-D-aspartate receptors (NMDAR), resulting in downregulation of GAD1 and Pvalb mRNA expression. B: following
4-aminopyridine (4AP) with glutamate receptor (4AP-GluX) blockers (PV cell activation only, pyramidal quiescence), Ca2 transients are still produced within
the PV cells, resulting in physiological levels of Ca2 and activation of the extracellular signal-related kinase mitogen-activated protein kinase (ERK MAPK)
pathway, which is upstream of GAD1 and Pvalb mRNA expression.
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to develop rational antiepileptogenic therapies. An important
clinical observation is that various triggers of epileptogenesis,
such as cerebrovascular accidents or trauma, lead to epilepsy
only in a proportion of cases. This inherent binary variability is
also seen in our gene transcription studies because our results
imply that a linear increase in pyramidal involvement in
pathological network events will, at some threshold, produce a
switch from upregulation to downregulation of mRNA expres-
sion of certain genes. Our experiments looked at just two key
genes, GAD1 and Pvalb, but epileptogenesis has been associ-
ated with changes in many thousands more (Hansen et al.
2014; Lachos et al. 2011; Rakhade et al. 2007), arising from
altered epigenetic mechanisms such as DNA methylation
(Miller-Delaney et al. 2012; Ryley Parrish et al. 2013). How-
ever, this proof-of-principle study serves to emphasize the
importance of investigating cell class-specific gene changes,
particularly with respect to variable interneuronal responses,
during epileptogenesis (e.g., Hortopan et al. 2010; Jiang et al.
2016; Schwaller et al. 2004).
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